300511 Shanghai Xuerong Bio-Technology
- 3.68
- -0.03-0.81%
Shanghai Xuerong Bio-Technology News
Shanghai Xuerong Bio-Technology: Announcement on Shanghai Xuerong Bio-Technology Co., Ltd.'s Repurchase of Subsidiary's Equity.
Shanghai Xuerong Bio-Technology: Announcement of Shanghai Xuerong Biotechnology Co., Ltd. on the 2023 Restricted Stock Incentive Plan for the first time, some reserved for the first time, the ownership conditions for the first vesting period were not fulfilled, and some restricted shares that were granted but not yet owned were abolished
Shanghai Xuerong Bio-Technology: Legal Opinion of Attorney Guo Hao (Shanghai) Office on the Cancellation of Part of the Restricted Stock Incentive Plan of Shanghai Xuerong Biotechnology Co., Ltd.'s 2023 Restricted Stock Incentive Plan
Shanghai Xuerong Bio-Technology: Shanghai Xuerong Biotechnology Co., Ltd.'s indicative announcement on shareholders' share reduction plans
Xuerong Biotech: Announcement of Shanghai Xuerong Biotechnology Co., Ltd. on the expiration of the company\'s controlling shareholder\'s co-actor share reduction plan
Xuerong Biotech: Announcement by Shanghai Xuerong Biotechnology Co., Ltd. on the completion of the repurchase and cancellation of some restricted shares
Xuerong Biotech: Announcement by Shanghai Xuerong Biotechnology Co., Ltd. on the expiration of the shareholders\' share reduction plan
Xuerong Biotech: Announcement by Shanghai Xuerong Biotechnology Co., Ltd. on the cancellation of the pledge of the controlling shareholder\'s shares
Xuerong Biotech: Legal opinion from Guohao Law Firm (Shanghai) on matters relating to the grant of Shanghai Xuerong Biotechnology Co., Ltd.\'s 2023 restricted stock incentive plan
Xuerong Biotech: Announcement by Shanghai Xuerong Biotechnology Co., Ltd. on granting some reserved restricted shares to the incentive targets of the 2023 Restricted Stock Incentive Plan
Xuerong Biotech: Shanghai Xuerong Biotechnology Co., Ltd.\'s 2023 restricted stock incentive plan reserve partial list of incentive targets (reservation grant date)
Xuerong Biotech: Audit opinion of the supervisory board of Shanghai Xuerong Biotechnology Co., Ltd. on the list of incentive targets reserved for part of the 2023 restricted stock incentive plan
Xuerong Biotech: Shanghai Xuerong Biotechnology Co., Ltd.\'s announcement on the progress of the company\'s controlling shareholder\'s concerted activist share holdings halfway through the planned period
Xuerong Biology: Shanghai Xuerong Biotechnology Co., Ltd. Simplified equity change report (Yang Yongping and Yinwan Huayi No. 1)
Xuerong Biotech: Prompt announcement by Shanghai Xuerong Biotechnology Co., Ltd. on the reduction of the holding and passive dilution ratio of the controlling shareholder, actual controller and their co-actors by more than 5% and changes in equity
Xuerong Biotech: Legal opinion from Guohao Law Firm (Shanghai) on matters relating to the repurchase and cancellation of Shanghai Xuerong Biotechnology Co., Ltd.'s 2020 restricted stock incentive plan
Xuerong Biotech: Announcement of Shanghai Xuerong Biotechnology Co., Ltd. on the first grant of the 2020 restricted stock incentive plan, the suspension of the grant of part of the third unlocking period for which performance did not meet standards, and th
Xuerong Biotech: Anxin Securities Co., Ltd.'s inspection opinion on Shanghai Xuerong Biotechnology Co., Ltd.'s change in capital raising investment projects by issuing shares to specific targets
Xuerong Biotech: Announcement by Shanghai Xuerong Biotechnology Co., Ltd. on the pledge of some of the shares of the controlling shareholder
Xuerong Biotech: Audit opinion of the supervisory board of Shanghai Xuerong Biotechnology Co., Ltd. on the list of incentive recipients for the first day of the 2023 Restricted Stock Incentive Plan
Analysis
Price Target
No Data
No Data